centurion physical therapy and associates, p.c.

11 west 67th street
new york, new york 10023

NYS Entity Status
ACTIVE

NYS Filing Date
DECEMBER 23, 2013

NYS DOS ID#
4504454

County
NEW YORK

Jurisdiction
NEW YORK

Registered Agent
NONE

NYS Entity Type
DOMESTIC PROFESSIONAL CORPORATION

Name History
2013 - CENTURION PHYSICAL THERAPY AND ASSOCIATES, P.C.









Buffer



submit to reddit

Telephone
n/a

Fax
n/a

Website
n/a

Email address
n/a

LinkedIn
n/a

Facebook
n/a

Google+
n/a

Twitter
n/a

Pinterest
n/a

Instagram
n/a



  • Around the Web

  • Potential Pelosi replacement compares ‘tough cookie’ Dem to ‘Caesar’
    By Mark Moore - Sunday Jun 25, 2017

    Rep. Joe Crowley whose name has been floated as a challenger to Nancy Pelosi lauded the embattled House Democratic leader on Sunday as a “tough cookie” and a modern-day “Caesar.” “This is one of the smartest and hardest-working members. If we were living during the Roman E mpire, she would be a centurion’s centurion. In...

    Source: New York Post: News
  • Stealthy NY Startup Rocket Pharma Merges With Inotek, Heads to Nasdaq
    By Ben Fidler - Tuesday Sep 12, 2017

    Rocket Pharmaceuticals, a stealthy gene therapy startup in New York City, has made its first splash. Through a merger with struggling Inotek Pharmaceuticals (NASDAQ: ITEK), Rocket, a company developing treatments for a variety of rare blood diseases, has taken itself public. Rocket shareholders are expected to own 81 percent of the combined company, with Inotek […]

    Source: Xconomy New York
  • The Rebuilding Years, Post-Sandy
    By THE NEW YORK TIMES and JONAH MARKOWITZ - Sunday Oct 29, 2017

    Those affected by Hurricane Sandy five years ago shared how the storm changed their lives physically, emotionally and financially, and how things have changed for the better since.

    Source: NYT > Home Page
  • New Skin for 7-Year-Old Boy Marks Advance in Gene Therapy
    Wednesday Nov 8, 2017

    In a significant advance in organ regeneration and gene therapy, researchers created a new, healthy skin that covers almost the entire body of a 7-year-old boy with a life-threatening genetic disorder associated with skin blistering.

    Source: The Wall Street Journal: World News
  • FDA Refuses to Review Acorda Parkinson’s Drug, Shares Tumble
    By Ben Fidler - Tuesday Aug 29, 2017

    The heat is on Acorda Therapeutics once again. Months after Acorda lost a key group of patents, the FDA has declined to review, at least for now, an experimental Parkinson’s disease drug that is critical to the company’s future. Acorda (NASDAQ: ACOR) said this morning that the FDA has sent the Ardsley, NY, company a […]

    Source: Xconomy New York